Drug Shortage Report for RECOMBIVAX HB

Last updated on 2019-09-09 History
Report ID 52350
Drug Identification Number 02245977
Brand name RECOMBIVAX HB -(ADULT DIALYSIS-PRESERVATIVE FREE)
Common or Proper name (hepatitis B vaccine [recombinant])
Company Name MERCK CANADA INC
Active Ingredient(s) HEPATITIS B SURFACE ANTIGEN
Strength(s) 40MCG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR
Packaging size 1DOSE VIAL
ATC code J07BC
ATC description VIRAL VACCINES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2018-06-18
Actual start date 2018-06-18
Estimated end date 2021-03-01
Actual end date
Shortage status Actual shortage
Updated date 2019-09-09
Company comments
Health Canada comments
Contact Address 16750 ROUTE TRANSCANADIENNE
KIRKLAND, QUEBEC
CANADA H9H 4M7
Company contact information 1-800-567-2594 medinfocanada@merck.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v18 2019-09-09 French Compare
v17 2019-09-09 English Compare
v16 2019-07-04 French Compare
v15 2019-07-04 English Compare
v14 2019-07-04 English Compare
v13 2018-12-11 English Compare
v12 2018-10-15 English Compare
v11 2018-10-15 English Compare
v10 2018-10-15 English Compare
v9 2018-08-30 English Compare
v8 2018-06-19 English Compare
v7 2018-06-18 French Compare
v6 2018-06-18 English Compare
v5 2018-06-14 English Compare
v4 2018-06-14 English Compare
v3 2018-06-13 French Compare
v2 2018-06-13 English Compare
v1 2018-06-13 English Compare